Solid Biosciences (SLDB) Other Non-Current Assets (2017 - 2026)
Quarterly results put Other Non-Current Assets at $708000.0 for Q1 2026, down 64.12% from a year ago — trailing twelve months through Mar 2026 was $708000.0 (down 64.12% YoY), and the annual figure for FY2025 was $768000.0, down 60.66%.
Solid Biosciences has reported Other Non-Current Assets over the past 10 years, most recently at $708000.0 for Q1 2026.
- Other Non-Current Assets reached $708000.0 in Q1 2026 per SLDB's latest filing, down from $768000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.1 million in Q1 2022 and bottomed at $209000.0 in Q4 2023.
- Median Other Non-Current Assets over the past 5 years was $1.8 million (2022), compared with a mean of $1.7 million.
- The largest annual shift saw Other Non-Current Assets crashed 88.6% in 2023 before it surged 833.97% in 2024.
- Over 5 years, Other Non-Current Assets stood at $1.8 million in 2022, then plummeted by 88.6% to $209000.0 in 2023, then soared by 833.97% to $2.0 million in 2024, then crashed by 60.66% to $768000.0 in 2025, then dropped by 7.81% to $708000.0 in 2026.
- Business Quant data shows Other Non-Current Assets for SLDB at $708000.0 in Q1 2026, $768000.0 in Q4 2025, and $1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.13 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 708,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 708,000.00 |
| Dec 31, 2025 | 768,000.00 |
| Sep 30, 2025 | 1.92 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 1.97 Mn |
| Dec 31, 2024 | 1.95 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Dec 31, 2023 | 209,000.00 |
| Sep 30, 2023 | 1.83 Mn |
| Jun 30, 2023 | 1.83 Mn |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 1.83 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 1.83 Mn |
| Mar 31, 2022 | 2.07 Mn |
| Dec 31, 2021 | 2.07 Mn |
| Sep 30, 2021 | 2.07 Mn |
| Jun 30, 2021 | 2.07 Mn |
| Mar 31, 2021 | 327,000.00 |
| Dec 31, 2020 | 327,000.00 |
| Sep 30, 2020 | 327,000.00 |
| Jun 30, 2020 | 327,000.00 |
| Mar 31, 2020 | 327,000.00 |
| Dec 31, 2019 | 327,000.00 |
| Sep 30, 2019 | 327,000.00 |
| Jun 30, 2019 | 327,000.00 |
| Mar 31, 2019 | 327,000.00 |
| Dec 31, 2018 | 327,000.00 |
| Sep 30, 2018 | 209,000.00 |
| Jun 30, 2018 | 209,000.00 |
| Mar 31, 2018 | 209,000.00 |
| Dec 31, 2017 | 65,000.00 |
| Sep 30, 2017 | 97,000.00 |
| Jun 30, 2017 | 161,000.00 |
| Mar 31, 2017 | 165,000.00 |